294 related articles for article (PubMed ID: 32122916)
21. Hepatitis C virus hijacks host lipid metabolism.
Syed GH; Amako Y; Siddiqui A
Trends Endocrinol Metab; 2010 Jan; 21(1):33-40. PubMed ID: 19854061
[TBL] [Abstract][Full Text] [Related]
22. Functional Characterization of Apolipoproteins in the HCV Life Cycle.
Qiao L; Luo GG
Methods Mol Biol; 2019; 1911():235-246. PubMed ID: 30593630
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis C virus, cholesterol and lipoproteins--impact for the viral life cycle and pathogenesis of liver disease.
Felmlee DJ; Hafirassou ML; Lefevre M; Baumert TF; Schuster C
Viruses; 2013 May; 5(5):1292-324. PubMed ID: 23698400
[TBL] [Abstract][Full Text] [Related]
24. Perilipin-2 is critical for efficient lipoprotein and hepatitis C virus particle production.
Lassen S; Grüttner C; Nguyen-Dinh V; Herker E
J Cell Sci; 2019 Jan; 132(1):. PubMed ID: 30559250
[TBL] [Abstract][Full Text] [Related]
25. N-Myc Downstream-Regulated Gene 1 Restricts Hepatitis C Virus Propagation by Regulating Lipid Droplet Biogenesis and Viral Assembly.
Schweitzer CJ; Zhang F; Boyer A; Valdez K; Cam M; Liang TJ
J Virol; 2018 Jan; 92(2):. PubMed ID: 29118118
[TBL] [Abstract][Full Text] [Related]
26. A serum protein factor mediates maturation and apoB-association of HCV particles in the extracellular milieu.
Denolly S; Granier C; Fontaine N; Pozzetto B; Bourlet T; Guérin M; Cosset FL
J Hepatol; 2019 Apr; 70(4):626-638. PubMed ID: 30553840
[TBL] [Abstract][Full Text] [Related]
27. Very-low-density lipoprotein (VLDL)-producing and hepatitis C virus-replicating HepG2 cells secrete no more lipoviroparticles than VLDL-deficient Huh7.5 cells.
Jammart B; Michelet M; Pécheur EI; Parent R; Bartosch B; Zoulim F; Durantel D
J Virol; 2013 May; 87(9):5065-80. PubMed ID: 23427158
[TBL] [Abstract][Full Text] [Related]
28. Spatiotemporal Coupling of the Hepatitis C Virus Replication Cycle by Creating a Lipid Droplet- Proximal Membranous Replication Compartment.
Lee JY; Cortese M; Haselmann U; Tabata K; Romero-Brey I; Funaya C; Schieber NL; Qiang Y; Bartenschlager M; Kallis S; Ritter C; Rohr K; Schwab Y; Ruggieri A; Bartenschlager R
Cell Rep; 2019 Jun; 27(12):3602-3617.e5. PubMed ID: 31216478
[TBL] [Abstract][Full Text] [Related]
29. Assembly of infectious hepatitis C virus particles.
Bartenschlager R; Penin F; Lohmann V; André P
Trends Microbiol; 2011 Feb; 19(2):95-103. PubMed ID: 21146993
[TBL] [Abstract][Full Text] [Related]
30. Entangled in a membranous web: ER and lipid droplet reorganization during hepatitis C virus infection.
Meyers NL; Fontaine KA; Kumar GR; Ott M
Curr Opin Cell Biol; 2016 Aug; 41():117-24. PubMed ID: 27240021
[TBL] [Abstract][Full Text] [Related]
31. Cellular lipid droplets and hepatitis C virus life cycle.
Fukasawa M
Biol Pharm Bull; 2010; 33(3):355-9. PubMed ID: 20190392
[TBL] [Abstract][Full Text] [Related]
32. Cortactin Interacts with Hepatitis C Virus Core and NS5A Proteins: Implications for Virion Assembly.
Nguyen LP; Nguyen TTT; Nguyen HC; Pham HT; Han KM; Choi DH; Park EM; Kang SM; Tark D; Lim YS; Hwang SB
J Virol; 2020 Sep; 94(19):. PubMed ID: 32727880
[TBL] [Abstract][Full Text] [Related]
33. ARF1 activation dissociates ADRP from lipid droplets to promote HCV assembly.
Zhang N; Yin P; Zhou L; Li H; Zhang L
Biochem Biophys Res Commun; 2016 Jun; 475(1):31-6. PubMed ID: 27157138
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis C Virus-Induced Rab32 Aggregation and Its Implications for Virion Assembly.
Pham TM; Tran SC; Lim YS; Hwang SB
J Virol; 2017 Feb; 91(3):. PubMed ID: 27852857
[TBL] [Abstract][Full Text] [Related]
35. Complex lipid metabolic remodeling is required for efficient hepatitis C virus replication.
Hofmann S; Krajewski M; Scherer C; Scholz V; Mordhorst V; Truschow P; Schöbel A; Reimer R; Schwudke D; Herker E
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Sep; 1863(9):1041-1056. PubMed ID: 29885363
[TBL] [Abstract][Full Text] [Related]
36. Interplay between hepatitis C virus and lipid metabolism during virus entry and assembly.
Lavie M; Dubuisson J
Biochimie; 2017 Oct; 141():62-69. PubMed ID: 28630011
[TBL] [Abstract][Full Text] [Related]
37. Extracellular lipid-free apolipoprotein E inhibits HCV replication and induces ABCG1-dependent cholesterol efflux.
Crouchet E; Lefèvre M; Verrier ER; Oudot MA; Baumert TF; Schuster C
Gut; 2017 May; 66(5):896-907. PubMed ID: 27609828
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis C virus-apolipoprotein interactions: molecular mechanisms and clinical impact.
Crouchet E; Baumert TF; Schuster C
Expert Rev Proteomics; 2017 Jul; 14(7):593-606. PubMed ID: 28625086
[TBL] [Abstract][Full Text] [Related]
39. Human Cathelicidin Compensates for the Role of Apolipoproteins in Hepatitis C Virus Infectious Particle Formation.
Puig-Basagoiti F; Fukuhara T; Tamura T; Ono C; Uemura K; Kawachi Y; Yamamoto S; Mori H; Kurihara T; Okamoto T; Aizaki H; Matsuura Y
J Virol; 2016 Oct; 90(19):8464-77. PubMed ID: 27440892
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis C virus particles and lipoprotein metabolism.
André P; Perlemuter G; Budkowska A; Bréchot C; Lotteau V
Semin Liver Dis; 2005 Feb; 25(1):93-104. PubMed ID: 15732001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
